Hamish Norton - 16 Jun 2026 Form 4 Insider Report for Cadre Holdings, Inc. (CDRE)

Reporting relationship: Director
Issuer ticker: CDRE
Reported as of: 16 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 18 Jun 2026, 16:19:33 UTC
Prior SEC filing: 16 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Hamish Norton

Key filing fact

Hamish Norton filed Form 4 for Cadre Holdings, Inc. (CDRE) on 18 Jun 2026.

Key facts

This page summarizes Hamish Norton's Form 4 filing for Cadre Holdings, Inc. (CDRE).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 18 Jun 2026, 16:19.

Change

Previous filing in this sequence was filed on 16 Jun 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001873521 Primary reporting owner

Norton Hamish

Relationship: Director
Address: C/O CADRE HOLDINGS, INC., 13386 INTERNATIONAL PKWY, JACKSONVILLE
Signature: /s/ Hamish Norton
Signature date: 18 Jun 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CDRE transaction Derivative

Stock Option (right to purchase)

Award

Transaction value
Shares: +17,393
Change %
Price: $0.000000^*
Shares after: 17,393
Date: 16 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 17,393
Exercise price: $28.75
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The option to purchase shares of Cadre Holdings, Inc. (the "Issuer") common stock, $0.0001 par value per share (the "Common Stock"), was granted under the Issuer's 2021 Stock Incentive Plan. Options to purchase 4,349 shares of the Issuer's Common Stock will vest and become exercisable on June 30, 2026, and options to purchase 4,348 shares of the Issuer's Common Stock will vest and become exercisable on each of September 30, 2026, December 31, 2026, and March 31, 2027, respectively.